Canada - TSX Venture Exchange - TSX-V:RLV - CA75942W1023 - Common Stock
The current stock price of RLV.CA is 0.02 CAD. In the past month the price increased by 33.33%. In the past year, price decreased by -42.86%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| JWEL.CA | JAMIESON WELLNESS INC | 19.02 | 1.39B | ||
| LOVE.CA | CANNARA BIOTECH INC | 12 | 159.43M | ||
| GENX.CA | GENIX PHARMACEUTICALS CORP | N/A | 1.53M |
Relevium Technologies, Inc. engages in identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets with a focus on E-Commerce. The company is headquartered in Montreal, Quebec. The company went IPO on 2012-12-21. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets, and cannabinoids. The firm operates through two wholly owned subsidiaries, including BGX E-Health LLC (BGX) and Biocannabix Health Corporation (BCX). The BGX markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals. The BCX is a biopharma nutraceutical Company, which is focused on delivering pediatric endo-medicinal nutraceuticals for therapy.
RELEVIUM TECHNOLOGIES INC
1000 Sherbrooke St W Suite 2700
MONTREAL QUEBEC H3A 3G4 CA
CEO: Aurelio Useche
Employees: 0
Phone: 15148248559.0
Relevium Technologies, Inc. engages in identification, evaluation, acquisition and operations of brands and businesses in the Health and Wellness markets with a focus on E-Commerce. The company is headquartered in Montreal, Quebec. The company went IPO on 2012-12-21. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets, and cannabinoids. The firm operates through two wholly owned subsidiaries, including BGX E-Health LLC (BGX) and Biocannabix Health Corporation (BCX). The BGX markets dietary supplements, nutraceuticals, sports nutrition and cosmeceuticals. The BCX is a biopharma nutraceutical Company, which is focused on delivering pediatric endo-medicinal nutraceuticals for therapy.
The current stock price of RLV.CA is 0.02 CAD.
RLV.CA does not pay a dividend.
RLV.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
RLV.CA stock is listed on the TSX Venture Exchange exchange.
RELEVIUM TECHNOLOGIES INC (RLV.CA) operates in the Consumer Staples sector and the Personal Care Products industry.
RELEVIUM TECHNOLOGIES INC (RLV.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
ChartMill assigns a technical rating of 3 / 10 to RLV.CA. When comparing the yearly performance of all stocks, RLV.CA is a bad performer in the overall market: 70.09% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to RLV.CA. RLV.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months RLV.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -122.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -698.01% | ||
| ROA | -25.8% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |